Hypertrophic and Keloid Scar Treatment Market to Reach $11.14 Billion by 2028, Growing at 9.8% CAGR

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Hypertrophic And Keloid Scar Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $11.14 billion In 2028 At A CAGR Of 9.8%:

The hypertrophic and keloid scar treatment market size has grown rapidly in recent years. It will grow from $6.91 billion in 2023 to $7.67 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to risen incidence of hypertrophic and keloid scars, advancements in scar assessment, widespread adoption of topical treatments, surgical and invasive procedures, patient demand for scar improvement.

The hypertrophic and keloid scar treatment market size is expected to see strong growth in the next few years. It will grow to $11.14 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to emerging minimally invasive interventions, advancements in scar revision techniques, growing interest in combination therapies, increasing awareness and early intervention, global aesthetic trends. Major trends in the forecast period include emerging injectable therapies, combination therapies for synergistic effects, patient-centric approaches, scar assessment technologies, telemedicine for follow-up and consultations.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=10692&type=smp

Hypertrophic And Keloid Scar Treatment Market Major Segments
The hypertrophic and keloid scar treatment market covered in this report is segmented -
1) By Treatment: Cryotherapy, Surgical Excision, Pressure Dressings, Intralesional 5-Fluorouracil, Superficial X-Ray, Intralesional Corticosteroid Injection, Other Treatments
2) By Products: Topical Products, Laser Products, Injectables, Other Products
3) By Scar: Hypertrophic Scars, Keloid Scars
4) By End-Use: Hospitals, Clinics, Other End-Users

Key Driver - Rising Road Accidents And Burn Cases Fuel Growth In Hypertrophic And Keloid Scar Treatment Market

An increase in the number of road accidents and burn cases is expected to propel the growth of the hypertrophic and keloid scar treatment market going forward. Road accidents refer to an accident that occurs on the road and involves at least one vehicle and people. Road accidents and burn cases require attention and appropriate measures to prevent them and provide effective treatment. Hypertrophic and keloid scar treatments are used to treat people who are injured in road accidents by lowering the scar's height and tightness. An increase in road accidents and burn cases contributes to the growth of the hypertrophic and keloid scar treatment market. For instance, in August 2022, according to the National Highway Traffic Safety Administration, a US-based agency of the federal government, part of the Department of Transportation, in the first three months of 2022, around 9,560 persons died in motor vehicle traffic accidents, an increase of nearly 7% compared to the 8,935 fatalities for the same period in 2021. Further, the mortality rate rose from the predicted rate of 1.25 fatalities per 100 million vehicle miles in the first quarter of 2021 to 1.27 fatalities per 100 million vehicle miles in the first quarter of 2022. Therefore, the increase in the number of road accidents and burn cases will drive the hypertrophic and keloid scar treatment market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=10692&type=smp

Prominent Trend - Clinically Proven Solution To Maximize Their Profits In The Market

Major companies in the hypertrophic and keloid scar treatment market are focusing on developing clinically proven solutions made from silicon, such as medical-grade silicone strips, to maximize their profits in the market. Medical-grade silicone strips are therapeutic products made from high-quality silicone material, specifically formulated to promote scar healing and reduction. For instance, in April 2023, Scar Erase, a UK-based company that provides silicone-based scar reduction therapy, launched Scar Erase silicone strips, a clinically tested and affordable solution for scar healing. Made from 3mm of medical-grade silicone, the strips aid in the treatment of various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. This silicone technology encapsulates the scar location, promoting hydration and an optimal healing environment, leading to significant reductions in scar texture, color, and height. It is designed for comfort and discretion, providing an accessible at-home scar treatment solution.

Hypertrophic And Keloid Scar Treatment Market Players
Major companies operating in the hypertrophic and keloid scar treatment market report are Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Mylan N.V., Stratpharma AG, Revitol Corporation Inc., Quantum Health, Scarfade, Biodermis, Renovo Group plc, Mederma, Silagen

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/hypertrophic-and-keloid-scar-treatment-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the hypertrophic and keloid scar treatment market in 2023. Asia-pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Hypertrophic And Keloid Scar Treatment Market Report Structure
3. Hypertrophic And Keloid Scar Treatment Market Trends And Strategies
4. Hypertrophic And Keloid Scar Treatment Market - Macro Economic Scenario
5. Hypertrophic And Keloid Scar Treatment Market Size And Growth
…..
27. Hypertrophic And Keloid Scar Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.